Reliance Power shares jump 2% as company signs commercial term sheet for long-term power purchase agreement with Green Digital, Bhutan
By Aman Shukla Published on May 19, 2025, 10:10 IST
Reliance Power shares surged over 2% in early trade after the company signed a commercial term sheet for a long-term Power Purchase Agreement (PPA) with Green Digital Private Limited (GDL), a subsidiary of Bhutan's Druk Holding and Investments Limited (DHI). As of 10:08 AM, the shares were trading 2.68% higher at Rs 46.28.
This milestone agreement paves the way for Bhutan's largest solar power project — a 500 MW plant to be developed under a 50:50 joint venture between Reliance Power and DHI. The Build-Own-Operate (BOO) model project will see an estimated investment of INR 2,000 crore, marking the largest foreign direct investment (FDI) in Bhutan's solar energy sector by a private entity.
Reliance Power has already initiated the EPC tendering process through international competitive bidding to ensure cost efficiency and high-quality execution. Financing discussions are underway with top financial institutions to secure long-tenor, sustainable project funding.
The project will be executed in phases over 24 months and is expected to significantly boost Bhutan's solar capacity, reducing reliance on hydropower and supporting South Asia's clean energy transition.
This initiative builds on the October 2024 strategic partnership between Reliance Enterprises (a JV of Reliance Power and Reliance Infrastructure) and DHI, which also includes the development of the 770 MW Chamkharchhu-I hydroelectric project.
With a clean energy pipeline of 2.5 GWp solar and 2.5 GWh Battery Energy Storage Systems (BESS), Reliance Power is strengthening its position as a major player in India's renewable energy sector.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at BusinessUpturn.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
2 hours ago
- Business Upturn
NHPC declares COD for 3rd phase of Karnisar Solar Power Project in Bikaner
NHPC Limited has announced the commencement of commercial operations for the third phase of its 300 MW Karnisar Solar Power Project in Bikaner, Rajasthan. Following the successful completion of the trial run on June 5, 2025, the company declared the Commercial Operation Date (COD) for the third phase—adding 53.57 MW of capacity—effective June 7, 2025. With this milestone, the total commercially operational capacity of the Karnisar Solar Power Project now stands at 160.71 MW out of the planned 300 MW. This phased commissioning highlights NHPC's continued commitment to expanding its renewable energy portfolio and supporting India's clean energy transition. The project is a part of NHPC's broader strategy to diversify its energy mix beyond hydropower and contribute significantly to the nation's solar capacity. It aligns with India's ambitious renewable energy goals and showcases NHPC's growing presence in the solar sector. NHPC Q4 Results NHPC has reported a strong 52% year-on-year (YoY) jump in its consolidated net profit to ₹919.63 crore for the fourth quarter ended March 2025, compared to ₹605 crore in the same quarter last year. According to the company's regulatory filing, the impressive performance was primarily driven by a rise in total income, which grew to ₹2,672.11 crore in Q4 FY25 from ₹2,320.18 crore in Q4 FY24. Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Upturn
19 hours ago
- Business Upturn
PNC Infratech bags Rs 239.94 crore flyover project in Rajasthan from PWD
PNC Infratech Limited has informed exchanges that the company bagged a Letter of Acceptance (LoA) dated June 6, 2025, from the Public Works Department (PWD) of Rajasthan for a significant infrastructure development project. The project entails the construction of a flyover from Heeradas Chouraha to Kumher Gate Chouraha in Bharatpur City, Rajasthan. The contract, awarded under the Engineering, Procurement, and Construction (EPC) model, is valued at ₹239.94 crore. The project is slated for completion within a period of 24 months. Advertisement This is a purely domestic contract with no promoter or promoter group interest involved in the awarding entity. The development is expected to significantly ease traffic congestion and enhance urban mobility in Bharatpur, a key city in Rajasthan. With this win, PNC Infratech further strengthens its presence in the road and infrastructure segment, aligning with its vision of contributing to India's growing urban infrastructure. PNC Infratech Q4 results PNC Infratech reported a sharp decline in its financial performance for the fourth quarter ended March 2025. The company's net profit plunged 81% year-on-year to ₹75.50 crore, compared to ₹395.90 crore in Q4 FY24. Revenue from operations also fell significantly by 34.5%, standing at ₹1,704 crore versus ₹2,600 crore in the same period last year. EBITDA for the quarter came in at ₹362 crore, down 51% from ₹736 crore a year ago. The EBITDA margin also shrunk to 21.26%, compared to 28.32% in Q4 FY24.
Business Upturn
21 hours ago
- Business Upturn
Lupin gets U.S. FDA tentative approval for Generic Oxcarbazepine ER Tablets
Lupin Limited has announced that it has received tentative approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Oxcarbazepine Extended-Release (ER) Tablets in 150 mg, 300 mg, and 600 mg strengths. These tablets are the generic equivalent of Oxtellar XR® ER Tablets by Supernus Pharmaceuticals and are indicated for the treatment of partial-onset seizures in patients aged 6 years and above. Lupin's version of the drug will be manufactured at its Nagpur facility in India. According to IQVIA MAT April 2025 data, Oxcarbazepine ER Tablets (RLD Oxtellar XR®) recorded estimated annual sales of USD 206 million in the United States, underscoring the potential market opportunity for Lupin. Headquartered in Mumbai, Lupin is a leading global pharmaceutical company with a strong footprint in the U.S. and India. The company focuses on a broad range of therapy areas including central nervous system disorders, respiratory, cardiovascular, anti-infective, and women's health. It operates 15 manufacturing sites and 7 research centers globally, supported by over 23,000 employees. Lupin continues to expand its U.S. portfolio of complex generics and remains committed to delivering high-quality, affordable medicines that improve health outcomes for patients around the world. Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
